Algorithms useful in the treatment of atrial fibrillation

被引:1
作者
Chaudhry, GM
Haffajee, CI
机构
[1] St Elizabeths Med Ctr, Boston, MA 02135 USA
[2] Tufts Univ, Sch Med, Medford, MA 02155 USA
关键词
D O I
10.1097/00001573-200201000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) is a heterogeneous disorder; its management must be individualized depending upon the mode of presentation, underlying substrate, and need for either rate or rhythm control, In hemodynamically unstable patients with new onset AF, conversion by electrical cardioversion is the preferred approach; however, in stable patients pharmacological options may be considered. Recurrence rate after conversion is high in the majority of patients, necessitating the use of antiarrhythmic agents, Because of modest efficacy and potential for untoward effects, various nonpharmacologic approaches are being explored. Some of these modalities are considered curative in the short-term but techniques are still being refined. Curr Opin Cardiol 2002, 17:52-57 (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 31 条
[1]  
Azpitarte J, 1997, EUR HEART J, V18, P1649
[2]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[3]  
*BOST AR ANT TRIAL, 1990, NEW ENGL J MED, V3, P1505
[4]   Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fibrillation [J].
Botto, GL ;
Bonini, W ;
Broffoni, T ;
Espureo, M ;
Cappelletti, G ;
Lombardi, R ;
Molteni, S ;
Pedraglio, E ;
Ferrari, G .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (11) :2480-2484
[5]   EFFICACY AND SAFETY OF QUINIDINE THERAPY FOR MAINTENANCE OF SINUS RHYTHM AFTER CARDIOVERSION - A METAANALYSIS OF RANDOMIZED CONTROL TRIALS [J].
COPLEN, SE ;
ANTMAN, EM ;
BERLIN, JA ;
HEWITT, P ;
CHALMERS, TC .
CIRCULATION, 1990, 82 (04) :1106-1116
[6]   SUCCESSFUL SURGICAL-TREATMENT OF ATRIAL-FIBRILLATION - REVIEW AND CLINICAL UPDATE [J].
COX, JL ;
BOINEAU, JP ;
SCHUESSLER, RB ;
FERGUSON, TB ;
CAIN, ME ;
LINDSAY, BD ;
CORR, PB ;
KATER, KM ;
LAPPAS, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (14) :1976-1980
[7]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788
[8]   Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter [J].
Falk, RH ;
Pollak, A ;
Singh, SN ;
Friedrich, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) :385-390
[9]   Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins [J].
Haïssaguerre, M ;
Jaïs, P ;
Shah, DC ;
Takahashi, A ;
Hocini, M ;
Quiniou, G ;
Garrigue, S ;
Le Mouroux, A ;
Le Métayer, P ;
Clémenty, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (10) :659-666
[10]   Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation [J].
Huang, DT ;
Monahan, KM ;
Zimetbaum, P ;
Papageorgiou, P ;
Epstein, LM ;
Josephson, ME .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1998, 9 (05) :462-469